Kettering General Hospital has embarked on a major medical records digitisation project with System C, IMMJ Systems and SPS, with over 220,000 medical records securely scanned into the IMMJ Systems MediViewer Electronic Document Management System.
Nottingham University Hospitals NHS Trust has selected Indica Labs to aid in digitisation of the pathology workflow. Indica Labs will deliver HALO AP software fully integrated with existing hospital systems, alongside Hamamatsu Nanozoomer scanners.
CheckUp Health is a brand-new digital healthcare provider offering private GP video and audio appointments to all UK residents from anywhere in the world, along with an array of rapidly growing services.
CrestOptics has been selected by Akoya Biosciences, The Spatial Biology Company, as a premier microscope provider to jointly develop new spatial biology and spatial phenotyping applications.
Biotage has launched the Biotage PhyPrep, a new automated platform for plasmid DNA purification that releases laboratory staff from the tedium of a repetitive, manual procedure.
Paige, Oxford University and NHS regional partners in the UK have won the Phase 4 Artificial Intelligence in Health and Care award from the NHS Accelerated Access Collaborative to study Paige Prostate in a cancer laboratory setting.
Genmed has announced a four-year collaboration with Cambridge University Hospitals NHS Foundation Trust to provide a vendor-neutral managed genomics laboratory service within Addenbrooke’s Hospital.
The Thermo Scientific SureTect Salmonella Species PCR Assay receives approval by AOAC International (AOAC-OMA claim) for a broad range of foods and selected environmental surfaces, including challenging, high-risk matrices and large sample sizes.
The British In Vitro Diagnostics Association (BIVDA) has launched the latest in its series of strategic papers, The Digital Revolution.
Proscia has introduced the next generation of its flagship Concentriq platform to help the world’s largest laboratory networks keep pace with the growing need for diagnostic services in the post-COVID era.
Beckman Coulter has announced the launch of an anti-Müllerian hormone (AMH) test that uses a validated cut-off to aid in the assessment of ovarian reserve and ovarian response as an aid for women undergoing in vitro fertilisation (IVF).